INTRODUCTION {#sec1-1}
============

Of the four species of malarial parasites that commonly cause infection in man, *Plasmodium falciparum* is responsible for virtually all the severe cases and deaths. The considerable mortality and morbidity in falciparum malaria is due to its protean manifestation, multi-organ involvement and delay in diagnosis and failure of administration of treatment promptly.\[[@ref1][@ref2]\] All cases of falciparum malaria are potentially severe and life threatening medical emergency. Malaria must be distinguished from other febrile illnesses including viral illnesses (such as dengue fever and influenza), typhoid, brucellosis, respiratory and urinary tract infections. The acute coma of cerebral malaria must be distinguished from viral encephalitis (herpes simplex, human immunodeficiency virus and enteroviral), bacterial meningoencephalitis (pyogenic and rarely tuberculous) and fungal meningoencephalitis, brain abscess, heat stroke, cerebrovascular events, hypertensive encephalopathy, intoxications with drugs and poisons as well as other causes of coma.\[[@ref1][@ref2]\] The renal failure of malaria must be distinguished from renal impairment due to other febrile illnesses such as leptospirosis. The jaundice and hepatomegaly of malaria should not be confused with that of viral hepatitis (hepatitis A virus, hepatitis B virus, hepatitis C virus), leptospirosis, drug-induced diseases and alcohol. Severe and complicated malaria is characterized by multiorgan involvement including ARF, acute lung injury (ALI) and ARDS. This study was conducted to review the complications of *P. falciparum* malaria at a tertiary care centre.

MATERIALS AND METHODS {#sec1-2}
=====================

This study was a retrospective observational study on complicated falciparum malaria conducted at Krishna institute of medical sciences Karad. This study is approved by ethical committee of Krishna institute of medical sciences, Karad. Adult patients with age \>18 years with smear positive falciparum malaria with various complications admitted to medical wards and intensive care unit (ICU) from January 2011 to December 2011 were included in this study. A total 47 patients with positive blood smear for *P. falciparum* malaria were included in present study with complicated *P. falciparum* malaria. The coexistence of other diseases like pneumonia, urinary tract infection, leptospirosis, H1N1 and viral hepatitis and mixed malarial infections were excluded from the present study by appropriate investigations.

Peripheral blood smears were collected on admission for Giemsa staining and subsequently every 12 and 48 hours to assess parasitemia. Blood was collected for estimation of glucose, urea, creatinine, serum electrolytes, liver function tests, haemoglobin, platelet count, total leukocyte count and prothrombin time (PT). Arterial blood gas analysis in patients with respiratory distress was done in 11 patients. Chest radiograph and electrocardiogram was done as and when needed for diagnosis of respiratory distress and pulmonary edema \[[Figure 1](#F1){ref-type="fig"}\]. The diagnosis of malaria was made with detection of asexual form of *P. falciparum* from Giemsa stained peripheral blood smear.\[[@ref2]\] In a patient with *P. falciparum* asexual parasitaemia and no other obvious cause of symptoms, the presence of one or more of the following clinical or laboratory features classifies the patient as suffering from severe malaria.

![Chest radiograph showing suggestive of ARDS in a patient with complicated falciparum malaria](TP-2-49-g001){#F1}

Severe complicated malaria was diagnosed according to the guidelines of World Health Organization. Cerebral malaria was diagnosed when a patient had unarousable coma using Glasgow Coma Scale with exclusion of other etiologies with multiple convulsions -- more than two episodes in 24 hours, renal failure, jaundice, hypoglycaemia and severe anemia were diagnosed when serum creatinine was more than 2.0 mg/dl, s. bilirubin was more than 2.0 mg/dl, random blood glucose was less than 60 mg/ dl and hemoglobin was less than 7.0 gm/dl, respectively. The metabolic acidosis was labeled if plasma bicarbonate \<15 mmol/l. Circulatory collapse (hypotension) had been defined as systolic blood pressure (BP) \<90 or a fall in BP of more than 40 mm of Hg unresponsive to fluid administration. Respiratory distress was defined when patient had tachypnoea with or without pulmonary edema (radiological).\[[@ref3][@ref4]\]

Patients with complication were grouped under single complication, two complications, three complications and multiple complications. Onset time, resolution time, duration, and progression of complications as well as duration of hospital stay were determined. The outcome was binary, i.e., either recovery or death. Airway was secured in unconscious patient, intravenous (IV) infusion of dextrose normal saline was started with central venous pressure (CVP) monitoring. In unconscious patients, lumbar puncture and cerebrospinal fluid (CSF) study was done to exclude bacterial/viral meningitis. Patients were examined and assessed frequently until full recovery or death. All patients were treated with intravenous quinine dihydrochloride at a loading dose of 20 mg/ kg administered over 3 h. Subsequent dose of 10 mg/ kg administered over 2 h every 8 h in a 10% dextrose solution until the patient could take medication orally. Treatment was continued for 7--10 days. Complications such as anemia, hypoglycaemia, convulsion, renal failure, jaundice, respiratory failure and circulatory collapse were treated according to the standard protocol. The data were pooled, computerized, and analyzed by evaluation version of EPI Info. 6 \[(Epi Info is public domain statistical software for epidemiology developed by Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia (USA)\]. Patient characteristics and the outcome of interest and relative risk and their corresponding 95% confidence interval were calculated. Prevalence rates were given in percentage. Various numbers are given as mean and standard deviation±1 SD. For continuous variable, mean values were compared using two sample *'t'* tests for independent samples. Categorical variables have been compared by using χ^2^ (Chi-square) test. The probability \<0.05 was considered as significant.

RESULTS {#sec1-3}
=======

A total 47 smear positive patients were included in present study with criterion fulfilling complicated *P. falciparum* malaria of both gender. Data was collected for this retrospective study from medical records of the institute. Total 39 (82.97%) were males and 8 (17.02%) were female patients with mean age of 29±11 years and 31±12 years for females. Out of total 47 patients, 27 (57.44%) patients were critically ill and treated in ICU and remaining 20 (42.55%) were managed in medical wards. All 47 (100%) patient had fever as a presenting complaint at the time of admission. Vomiting was present in 9 (19.14%) patients. Total 4 (8.5%) patients were unconscious and 4 (5.47%) patients had generalized tonic clonic convulsions. Three (6.38%) patients had hypoglycemia at the time of admission. Total 29 (61.70%) patients had jaundice. Total 4 (8.5%) patients had hypotension. Oliguria was present in 6 (12.76%) patients as a presenting feature. Breathlessness and cough was present in 5 (10.63%) patients with low SpO~2~. One (2.12%) patient had bleeding tendency in the form of malena and hematemesis. Splenomegaly was present in 27 (57.44%) patients and hepatomegaly was present in 25 (53.19%) patients. Total 20 (42.55%) patients had pallor \[[Table 1](#T1){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}\]. The mean and standard deviation (±1) of laboratory parameters is shown in [Table 2](#T2){ref-type="table"}.

###### 

Clinical profile of complicated malaria
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###### 

Mean and standard deviation of laboratory parameters
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Total 20 patients had jaundice with anemia. Total 9 (58.90%) patients had isolated jaundice, 2 (4.25%) had anemia, 6 (12.76%) had cerebral malaria. Total 6 (12.76%) had ARF, 5 (10.63%) had ALI/ARDS and one (2.12%) had thrombocytopenia. In present study most common presentation was with jaundice and anemia while ARF and ARDS were uncommon presentation with poor outcome and high mortality. Total 28 patients had single complication in the form of cerebral malaria 6(19.17%), jaundice 9 (20.54%), 4 (8.51%) had ARDS, 5 (10.63%) had ARF and anemia 2 (21.91%). Total 20 (42.55%) patients had two complications in the form of jaundice with anemia. One (2.12%) patient had four complications in the form of cerebral malaria with ARF, ARDS and thrombocytopenia. Patient with four complications succumbed. Total 5 (10.63%) had isolated cerebral malaria without other organ involvement. A total of 9 patients required blood transfusions for severe anemia. At the time of admission total 4 (8.51%) patients had shock which was treated by fluid resuscitation and inotropic agent support under CVP monitoring. A total of six patients developed ARF required renal replacement therapy in the form of hemodialysis (7±3 cycles). A total of 11 patients had acidic pH of which 6 (12.76%) had metabolic acidosis and 5 (10.63%) had respiratory acidosis which was corrected by hemodialysis, artificial ventilator and/or sodium bicarbonate supplementation. Out of 47 patients admitted and treated for complicated *P. falciparum* malaria, 42 (89.36%) patients were discharged in ambulatory state after recovery from complications and parasitic clearance \[[Table 3](#T3){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}\]. Six patient had oliguric renal failure and all of them required hemodialysis of which 5 (83.33%) recovered while one (16.66%) died. Five patients had pulmonary involvement in the form of ARDS of which all required artificial ventilator of which 3 (60%) succumbed \[[Table 4](#T4){ref-type="table"}\].

###### 

Clinical presentation and complications of falciparum malaria
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###### 

Comparison of case fatality rate amongst the complications of falciparum malaria
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Out of total 6 patients with cerebral malaria, 1 (16.66%) succumbed. Four patients developed isolated ARDS of which two (50%) succumbed. Five patients developed isolated ARF of which one (20%) succumbed. One (2.12%) patient had four complications in the form of cerebral malaria with ARF with ARDS with thrombocytopenia with 100% mortality. Case fatality rate was significantly high with ARDS compared to cerebral malaria and ARF with *'P'* = 0.0221 (odds ratio: 2.32). \[[Table 4](#T4){ref-type="table"}\].

A total of five patients succumbed with complicated *P. falciparum* malaria with case fatality rate of 10.63%. In univariate analysis overall case fatality rate was highest with pulmonary involvement (ARDS) compared with other complications which was statistically significant (*'P'*=0.0221). The case fatality rate with ARDS was 50% (2/4), with ARF was 20% (1/5) and with cerebral malaria it was 16.66% (1/6). Patients presented with hypotension had more incidence of ARF (4/6) compared to with normotension. Multi-organ failure associated with 100% mortality.

DISCUSSION {#sec1-4}
==========

In present study most common presentation was jaundice with anemia. ARF and ARDS were less common presentation with poor prognosis and significantly high mortality. A total of 26 (55.31%) patients had single complication. 20 (42.55%) patients had two complications in the form of jaundice with anemia. One (2.12%) patient had four complications in the form of cerebral malaria with ARF with ARDS with thrombocytopenia with 100% mortality. Five patients died with complicated *P. falciparum* malaria with case fatality rate of 10.63%. Cerebral malaria, ARF, ARDS, and thrombocytopenia are the less common presenting features in present study. Overall case fatality rate was highest with multi-organ dysfunction compared to single complication. Case fatality rate was highest in patients with ARDS compared to ARF, cerebral malaria with *'P'*=0.0221. We compared our results with various studies. Prakash *et al*.\[[@ref5]\] in their study quoted the mortality rate of 30.8% in complicated malaria with ARF which is comparable with present study in which mortality rate with ARF was 16. 66%. Mishra *et al*.,\[[@ref6]\] in their study stated that the case-fatality rate due to severe malaria is 10%--15% in spite of therapy but it increases in the presence of renal failure or respiratory distress (pulmonary edema or ARDS). In present study overall case fatality rate was (10.63%) and in patients with multi-organ dysfunction it was 100%. Kochar *et al*.,\[[@ref7]\] in their study reported the overall mortality of 11.09%; similarly in our study mortality rate was 10.63%. Morality was highest in ARDS (81.25%) which is comparable with our study where case fatality rate with multi-organ dysfunction was 60% with ARDS. Mishra *et al*.,\[[@ref8]\] in their study in eastern India found that 175 (23%) of the cases were fatal, mortality being particularly high (59%) among those with multiorgan failure. These findings are comparable with present study in which 1 (2.12%) patient had multiple complications in the form of ARF with ARDS with thrombocytopenia with 1 (100%) death. Total 5 patients died with complicated *P. falciparum* malaria with case fatality rate of 10.63%. The case fatality rate with ARDS was 60% (3/5), with ARF was 16.66% (1/6) and with cerebral malaria it was 16.66% (1/6). Case fatality rate was highest in patients with ARDS compared to ARF, cerebral malaria, jaundice and anemia with *'P'*\<0.0221. Jain *et al*.,\[[@ref9]\] in their study found that, ARF was present in 22% and respiratory distress was seen in 22% patients, Mortality was high among adults with multiple organ failures. Overall case fatality rate was 21%. These findings are similar to our study where 5 (10.63%) patients had ARDS and 6 (12.76%) had ARF. Chishti *et al*.,\[[@ref10]\] found that 90.63% of patients with falciparum malaria developed one or more complications. The most common complication is anemia accounting for 76.56% and total 12.5% died due to development of multiple complications. Similarly in our study 22 (46.80%) patients had anemia of which 20 (42.55%) had anemia with jaundice with mortality of 10.63%. Similarly Mohanty *et al*.,\[[@ref11]\] in their study of *P. falciparum* malaria patients quoted mortality of 13.65%. Prakash J *et al*.,\[[@ref12]\] reported *P. falciparum* with ARF in 79.61% of cases with mortality of 15.7%. Kanodia KV *et al*.,\[[@ref13]\] reported *P. falciparum* associated ARF in which 64% of the patients recovered completely. Similarly in our study all 6 (12.76%) patients required hemodialysis of which 4 (66.66%) recovered near total and 2 (33.33%) succumbed. Maheshwari A *et al*.,\[[@ref14]\] reported overall mortality rate of 18.5% and with multi-organ failure it was 33.3%. Kochar *et al*.,\[[@ref15]\] in their prospective study in Bikaner, Rajasthan (northwest India) 2001 found that jaundice (58.85%) followed by severe anemia (26.04%), shock (10.94%), cerebral malaria (10.94%), renal failure (6.25%) and ARDS (2.08%) were the complications seen in falciparum malaria. Similarly, the important cause of mortality in 2001 was multiple organ dysfunctions (71.10%) with predominant presentation of jaundice and renal failure. These findings are comparable with present study. Eryüksel *et al*.,\[[@ref16]\] Mohan *et al*.,\[[@ref17]\] and Manyindo *et al*,\[[@ref18]\] reported *P. falciparum* associated pulmonary complications in the form of ARDS with high mortality rate similar to present study. Eiam-Ong S *et al*.,\[[@ref19]\] stated renal involvement in *P. falciparum* similar to our study. This study highlights the ARDS and ARF are the main factors predicting mortality in complicated falciparum malaria.

CONCLUSION {#sec1-5}
==========

To conclude, unusual early isolated renal and pulmonary manifestations were the presenting feature of complicated *P. falciparum* malaria with high mortality as was seen in present study. The mortality rate was significantly high with multi-organ dysfunction. All the patients with ARF and ARDS had shock as a presenting feature. Multi-organ dysfunction had high case fatality rate (100%). Mainstay of treatment consists of appropriate antimalarial drug therapy, fluid replacement, early institution of artificial ventilation and renal replacement therapy. Invariably all the patients with ARF required daily dialysis. Severe ARF, and ALI/ARDS were poor prognostic factors in patients with *P. falciparum* infection in present study. The patients with ARDS should be managed in an ICU. Careful attention must be paid to hemodynamic stabilization and optimizing fluid balance. ARDS in malaria is a disease with a high mortality, and early diagnosis, institution of specific antimalarial treatment and assisted ventilation can be life-saving. This study confirms presence of complicated falciparum malaria with multi-organ dysfunction in western Maharashtra. *P. falciparum* malaria is an important treatable cause of ALI or ARDS and ARF in study population. *P. falciparum* malaria should be considered as an etiological agent for ARDS and ARF with multiple organ dysfunction syndrome in a clinical scenario of febrile illness.
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